In this Issue:
BRCA mutations and outcome to chemotherapy
Impact of ascites on surgical and clinical outcomes
Diagnostic value of PET/CT detection of ovarian cancer
Effect of obesity on recurrence in ovarian cancer
Effects of HA-CMC barrier on ovarian tumour progression
Carboplatin + paclitaxel weekly vs every 3 weeks in advanced ovarian cancer
Bevacizumab and risk factors for GI adverse events in advanced ovarian cancer
Risk estimation of BRCA1 or BRCA2 mutation by BRCAPRO
Impact of endometriosis on the risk and prognosis for ovarian cancer
Effectiveness of primary treatment for ovarian cancer
Please login below to download this issue (PDF)